Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

1.

Are we ready to predict late effects? A systematic review of clinically useful prediction models.

Salz T, Baxi SS, Raghunathan N, Onstad EE, Freedman AN, Moskowitz CS, Dalton SO, Goodman KA, Johansen C, Matasar MJ, de Nully Brown P, Oeffinger KC, Vickers AJ.

Eur J Cancer. 2015 Apr;51(6):758-66. doi: 10.1016/j.ejca.2015.02.002. Epub 2015 Feb 27. Review.

PMID:
25736818
2.

Late morbidity and mortality in patients with Hodgkin's lymphoma treated during adulthood.

Matasar MJ, Ford JS, Riedel ER, Salz T, Oeffinger KC, Straus DJ.

J Natl Cancer Inst. 2015 Feb 24;107(4). pii: djv018. doi: 10.1093/jnci/djv018. Print 2015 Apr.

PMID:
25717170
3.

Setd1a regulates progenitor B-cell-to-precursor B-cell development through histone H3 lysine 4 trimethylation and Ig heavy-chain rearrangement.

Tusi BK, Deng C, Salz T, Zeumer L, Li Y, So CW, Morel LM, Qiu Y, Huang S.

FASEB J. 2015 Apr;29(4):1505-15. doi: 10.1096/fj.14-263061. Epub 2014 Dec 30.

PMID:
25550471
4.

Histone Methyltransferase hSETD1A Is a Novel Regulator of Metastasis in Breast Cancer.

Salz T, Deng C, Pampo C, Siemann D, Qiu Y, Brown K, Huang S.

Mol Cancer Res. 2015 Mar;13(3):461-9. doi: 10.1158/1541-7786.MCR-14-0389. Epub 2014 Nov 4.

PMID:
25373480
5.

Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer.

Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO Jr, Goodman KA, Keating NL.

J Oncol Pract. 2014 Sep;10(5):e360-7. doi: 10.1200/JOP.2013.001309. Epub 2014 Jul 1.

6.

Overexpression of histone deacetylases in cancer cells is controlled by interplay of transcription factors and epigenetic modulators.

Yang H, Salz T, Zajac-Kaye M, Liao D, Huang S, Qiu Y.

FASEB J. 2014 Oct;28(10):4265-79. doi: 10.1096/fj.14-250654. Epub 2014 Jun 19.

PMID:
24948597
7.

Colorectal cancer survivors' needs and preferences for survivorship information.

Salz T, Baxi SS, Blinder VS, Elkin EB, Kemeny MM, McCabe MS, Moskowitz CS, Onstad EE, Saltz LB, Temple LK, Oeffinger KC.

J Oncol Pract. 2014 Jul;10(4):e277-82. doi: 10.1200/JOP.2013.001312. Epub 2014 Jun 3.

8.

Survivorship care plans: is there buy-in from community oncology providers?

Salz T, McCabe MS, Onstad EE, Baxi SS, Deming RL, Franco RA, Glenn LA, Harper GR, Jumonville AJ 4th, Payne RM, Peters EA, Salner AL, Schallenkamp JM, Williams SR, Yiee K, Oeffinger KC.

Cancer. 2014 Mar 1;120(5):722-30. doi: 10.1002/cncr.28472. Epub 2013 Dec 10.

9.

hSETD1A regulates Wnt target genes and controls tumor growth of colorectal cancer cells.

Salz T, Li G, Kaye F, Zhou L, Qiu Y, Huang S.

Cancer Res. 2014 Feb 1;74(3):775-86. doi: 10.1158/0008-5472.CAN-13-1400. Epub 2013 Nov 18.

10.

HIPAA: Training critical to protect patients, practice. .

Salz T.

Med Econ. 2013 Sep 25;90(18):43-4, 46-7. No abstract available.

PMID:
25509654
11.

Who gets genomic testing for breast cancer recurrence risk?

DeFrank JT, Salz T, Reeder-Hayes K, Brewer NT.

Public Health Genomics. 2013;16(5):215-22. doi: 10.1159/000353518. Epub 2013 Jul 30.

12.

USF1 and hSET1A mediated epigenetic modifications regulate lineage differentiation and HoxB4 transcription.

Deng C, Li Y, Liang S, Cui K, Salz T, Yang H, Tang Z, Gallagher PG, Qiu Y, Roeder R, Zhao K, Bungert J, Huang S.

PLoS Genet. 2013 Jun;9(6):e1003524. doi: 10.1371/journal.pgen.1003524. Epub 2013 Jun 6.

13.

Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.

Patel B, Kang Y, Cui K, Litt M, Riberio MS, Deng C, Salz T, Casada S, Fu X, Qiu Y, Zhao K, Huang S.

Leukemia. 2014 Feb;28(2):349-61. doi: 10.1038/leu.2013.158. Epub 2013 May 23.

PMID:
23698277
14.

YihE kinase is a central regulator of programmed cell death in bacteria.

Dorsey-Oresto A, Lu T, Mosel M, Wang X, Salz T, Drlica K, Zhao X.

Cell Rep. 2013 Feb 21;3(2):528-37. doi: 10.1016/j.celrep.2013.01.026. Epub 2013 Feb 14.

15.

Ethnic disparities in colonoscopy use among colorectal cancer survivors: a systematic review.

Salz T, Woo H, Starr TD, Jandorf LH, DuHamel KN.

J Cancer Surviv. 2012 Dec;6(4):372-8. doi: 10.1007/s11764-012-0231-0. Epub 2012 Oct 4. Review.

16.

Primary care providers' needs and preferences for information about colorectal cancer survivorship care.

Salz T, Oeffinger KC, Lewis PR, Williams RL, Rhyne RL, Yeazel MW.

J Am Board Fam Med. 2012 Sep-Oct;25(5):635-51. doi: 10.3122/jabfm.2012.05.120083.

17.

Carefully discharge difficult patients.

Salz T.

Med Econ. 2012 Jul 10;89(13):38-40. No abstract available.

PMID:
24383343
18.

Employee trust key to a strong practice.

Salz T.

Med Econ. 2012 Jun 25;89(12):30-1. No abstract available.

PMID:
24383201
20.

Survivorship care plans in research and practice.

Salz T, Oeffinger KC, McCabe MS, Layne TM, Bach PB.

CA Cancer J Clin. 2012 Mar-Apr;62(2):101-17. doi: 10.3322/caac.20142. Epub 2012 Jan 12. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk